APR-246 targets mutant p53 through its conversion to reactive electrophile methylene quinuclidinone (MQ) and binding the p53 core domain, thereby restoring p53 tumor suppressing, proapoptotic and cell arrest functions [35]. Here, TP53 is linked to neoplasm.